🇺🇸 SALICYLAMIDE in United States

834 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain — 109 reports (13.07%)
  2. Constipation — 89 reports (10.67%)
  3. Hypotension — 89 reports (10.67%)
  4. Fall — 88 reports (10.55%)
  5. Toxicity To Various Agents — 81 reports (9.71%)
  6. Dyspnoea — 78 reports (9.35%)
  7. Depressed Level Of Consciousness — 77 reports (9.23%)
  8. Balance Disorder — 75 reports (8.99%)
  9. Blood Calcium Decreased — 74 reports (8.87%)
  10. Cognitive Disorder — 74 reports (8.87%)

Source database →

SALICYLAMIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SALICYLAMIDE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for SALICYLAMIDE in United States?

Marketing authorisation holder not available in our data.